Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07832331 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Single Dose 4-Aminopyridine for Diagnosing Recurrent Laryngeal Nerve Paralysis Continuity After Trauma

StatusNot Yet Recruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study aims to evaluate the role of single-dose 4-aminopyridine on the diagnosis of recurrent laryngeal nerve (RLN) paralysis. In addition, the investigational treatment will be used to test the hypothesis that 4-aminopyridine can speed the determination of nerve continuity after RLN injuries.
Trial Details
NCT Number NCT07832331
Lead Sponsor Milton S. Hershey Medical Center
Conditions
(from sponsor)		 Vocal Cord Paralysis, Recurrent Laryngeal Nerve Palsy
Related terms Vocal Cord Paralysis
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov